Intern Pocket Cards - Antibiogram and Susceptibilities

VRE - MRSA - GRAM POSITIVES - GRAM NEGATIVES - PSEUDOMONAS - ANAEROBES - ATYPICALS - ANAEROBES - ATYPICALS

 - penicillin, amoxicillin/ampicillin, amox-clav/amp-sulbactam, methicillin/oxacillin, piperacilin-tazobactam/ticarcillin-clavulanate

 - 1st gen cephalosporins, 2nd gen cephalosporins (cefoxitin,cefotetan), 3rd gen cephalosporins, 4th gen cephalosporins (cefepime), (ceftazidime), 5th gen cephalosporins (ceftaroline)

 - carbapenems, aztreonam

 - ceftaz-avi, ceftolozane-tazo, mero-vabor / imi-relee, cefiderocol

 - TMP-SMX

 - clindamycin

 - vancomycin / oritavancin / dalbavancin

 - daptomycin, linezolid / tedizolid

 - tetracyclines (doxycycline)

 - tigecycline / eravacycline / omadacycline

 - lefamulin

 - macrolides

 - quinolones (delafloxacin, moxifloxacin)

 - aminoglycosides

 - fosfomycin

 - colistin / polymyxin B

 - metronidazole



Antimicrobial Stewardship:

 → What syndrome? (e.g., UTI, bacteremia, etc.) What bug? (Use culture data. If none, what is most likely?)

 → What drug? (IV or PO?) Check local antibiogram. Initial duration of therapy?

 → Can I de-escalate? If on IV, can I switch to PO? Can I stop? (Use clinical data like vitals, WBC count and cultures to tailor therapy)

 → Discharge patient - Confirm type of IV access (if indicated) and if frequency of medication and lab is feasible at discharge destination



by Jennifer Fulcher, MD, PhD @FulchJen



Full Inpatient Pocket Cards Collection: https://bit.ly/pocketcardset



#Antibiogram #Susceptibilities #antibiotics #management #pharmacology